BMDSys
english   |   deutsch
 
Company

“We aim at the transformation of an optimum scientific performance into products which satisfy our customers.“

We create solutions for internationally relevant medical challenges. Our success is based on innovative ideas, their realization with the highest possible scientific standards and on the development and precise fabrication of our products. To achieve these goals we rely on decades of profound knowledge, expertise, on the motivation and innovation power of our team.

We concentrate our activities on research and development of cardiologic diagnostics. Working in this field is especially rewarding because we can contribute significantly to the solution of challenges in healthcare, especially in early diagnosis. We are convinced that the Magnetic Field Imaging system (MFI) developed by BMDSys has the potential to revolutionize the clinical routine diagnostics in cardiology. Its establishment in clinical routine and the market leadership in biomagnetic diagnostic systems are BMDSys´ main goals.

BMDSys developed and syntonized the larger part of components which result in a Single Pass MFI system applicable in the clinical routine of a cardiologic everyday practice.

It is our vision that MFI will be the gold standard in leading cardiologic clinics in the foreseeable future. In the next step we imagine cardiologist practices, equipped with a new sensor concept based on the laser technology, to work with this system. It is our long-term goal to extend the diagnosable range of indications.

 

 

Among our investors are

IMEDCO AG (Haegendorf, Switzerland)

Wellington Partners (München)

IBG Beteiligungsgesellschaft Sachsen-Anhalt (Magdeburg)

National Technology Enterprises Company (NTEC) (Kuwait)

KfW Bankengruppe (Bonn)

 

 
NEWS
Nov 28, 2008
Certified Quality System: ISO13485

The quality management system of BMDSys has been certified to ISO13485

Jul 28, 2008
Results of CARDIOSTIM: MFI – best support in cardiac risk stratification

Implantable defibrillators are a useful protection against sudden cardiac death – if implanted to the “right” patients. Therefore identification of these risk groups is an important aspect in cardiological diagnostic.

 
BMDSys GmbH
Wildenbruchstr. 15
D-07745 Jena, Germany
Phone: +49 3641 23 58 51
Fax: +49 3641 23 61 55
Mail: info@bmdsys.com